Showing results (311-320 of 1,782) with videos related to

Sort By:
Pageof 179
Dermatology and Therapy|December 12, 2025
Summary of Research: Apremilast in Japanese Patients with Palmoplantar Pustulosis: A Randomized, Phase 3 TrialTadashi Terui, Yukari Okubo, Satomi Kobayashi, et al.
Dermatology and Therapy|November 8, 2025
Comparison of All-Cause Mortality in Generalized Pustular Psoriasis and Plaque Psoriasis: A Systematic Review and Meta-AnalysisBruce Strober, Lluís Puig, Mark G Lebwohl, et al.
Dermatology and Therapy|July 2, 2025
Efficacy and Safety of Cold Atmospheric Plasma-Assisted Therapy for Herpes Zoster: A Randomized, Parallel, Positive-Controlled, Non-inferiority Multicenter Clinical TrialJingwen Wang, Ke Xue, Jing Gao, et al.
Dermatology and Therapy|July 8, 2025
Translational Pharmacokinetics of Icotrokinra, a Targeted Oral Peptide that Selectively Blocks Interleukin-23 Receptor and Inhibits SignalingBeverly Knight, Brinda Tammara, Nishit B Modi, et al.
Dermatology and Therapy|July 7, 2025
Therapeutic Burden as Predictor of Response to Baricitinib for Alopecia Areata in Real Life: Prospective StudyDaniel Muñoz-Barba, Alberto Soto-Moreno, Sofía Haselgruber-de Francisco, et al.
Dermatology and Therapy|September 26, 2025
Physician-Reported Treatment Patterns in Moderate to Severe Chronic Hand Eczema: the RWEAL Multinational Medical Chart ReviewAna Giménez-Arnau, Anthony Bewley, Christian Apfelbacher, et al.
Dermatology and Therapy|October 14, 2025
Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia AreataBrett King, Amy McMichael, Rodney Sinclair, et al.
Dermatology and Therapy|September 15, 2025
Comparative Analysis of Patient-Reported Outcomes in Chronic Pruritus: Patients with Chronic Liver or Kidney Diseases Exhibit Higher Psychological Distress than Those with Atopic DermatitisSvenja Royeck, Christian Mess, Angelika Weigel, et al.
Dermatology and Therapy|September 23, 2025
Do Allergic Comorbidities Alter the Efficacy and Safety of Abrocitinib or Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis?Eric L Simpson, Jonathan I Silverberg, Bob Geng, et al.
Dermatology and Therapy|September 19, 2025
Brodalumab as a Second-Line Therapy in Psoriasis: Rapid Response and Unique Mechanism of Action After Biologic FailureLawrence Green, April Armstrong, George Han, et al.
Pageof 179